Loading...
•
Dec 31, 2019
Inogen Q4 2019 Earnings Report
Inogen's revenue declined due to decrease in direct-to-consumer, domestic business-to-business, and international business-to-business sales.
Key Takeaways
Inogen reported a decline in total revenue for the fourth quarter of 2019, with decreases in direct-to-consumer, domestic business-to-business, and international business-to-business sales. The company experienced an operating loss and a net loss for the quarter, with a decrease in total gross margin. However, the company is maintaining its full year 2020 total revenue guidance.
Total revenue decreased by 8.8% to $78.9 million compared to the same period in 2018.
Direct-to-consumer sales declined by 2.8% to $35.8 million.
The company reported an operating loss of $5.3 million, compared to an operating income of $4.8 million in the same period in 2018.
Net loss was $1.4 million, compared to net income of $10.0 million in the fourth quarter of 2018.
Revenue by Segment
Forward Guidance
Inogen is maintaining its full year 2020 total revenue guidance range provided on January 13, 2020 of $385 to $400 million, representing growth of 6.4% to 10.5% versus 2019 full year results. The Company is reducing its full year 2020 GAAP net income guidance range to $14 to $18 million from the range of $25 to $27 million provided on November 5, 2019, compared to 2019 GAAP net income of $21.0 million. Inogen is lowering its guidance range for full year 2020 Adjusted EBITDA to $44 to $50 million from the range of $56 to $58 million provided on November 5, 2019, compared to 2019 Adjusted EBITDA of $43.3 million.
Positive Outlook
- Direct-to-consumer sales expected to be the fastest-growing channel.
- Domestic and international business-to-business sales expected to have solid growth.
- Rental revenue expected to grow modestly due to increase in patients on service.
- Rental revenue expected to grow modestly due to low, single-digit percent rate increase in 2020 for Medicare beneficiaries.
- Net positive cash flow expected for 2020 with no additional equity capital required.
Challenges Ahead
- Minimal contribution of the Inogen Tidal Assist Ventilator for revenue in both the domestic business-to-business and direct-to-consumer channels in 2020.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...